Academic Journal
The role of biologics in the treatment of chronic granuloma annulare
| العنوان: | The role of biologics in the treatment of chronic granuloma annulare |
|---|---|
| المؤلفون: | Chen, Alessandra, Truong, Allison K., Worswick, Scott |
| المصدر: | International Journal of Dermatology ; volume 58, issue 5, page 622-626 ; ISSN 0011-9059 1365-4632 |
| بيانات النشر: | Wiley |
| سنة النشر: | 2019 |
| المجموعة: | Wiley Online Library (Open Access Articles via Crossref) |
| الوصف: | Background Granuloma annulare ( GA ), a benign inflammatory skin disease, is considered a Th1‐type delayed hypersensitivity reaction. Localized GA is likely to resolve spontaneously, whereas disseminated GA ( DGA ) may persist for decades and can be resistant to treatment. Biologics including TNF ‐α inhibitors have been proposed and utilized as salvage therapy for GA and other related diseases, interstitial granulomatous dermatitis ( IGD ), and actinic granuloma ( AG ). Methods A systematic review was conducted using the combination of search terms “granuloma annulare,” “interstitial granulomatous dermatitis,” or “actinic granuloma” and either “biologics,” “etanercept,” “adalimumab,” “infliximab,” “ustekinumab,” “ixekizumab,” “secukinumab,” “guselkumab,” “golimumab,” “brodalumab,” “tildrakizumab,” or “certolizumab” from the years 1970–2017. Results Review of the literature revealed that 79.3% of the patients with GA , IGD , or AG who had been treated with demonstrated TNF ‐α inhibitor therapy a clinical response. Conclusions TNF ‐α inhibitor therapy has been used to treat chronic GA , IGD , and AG that involved extensive body surface areas. However, the literature is limited to case series lacking control groups. Randomized, controlled trials are required to establish evidence‐based treatment of GA and related cutaneous, granulomatous conditions. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1111/ijd.14350 |
| الاتاحة: | http://dx.doi.org/10.1111/ijd.14350 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijd.14350 https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.14350 https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ijd.14350 |
| Rights: | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| رقم الانضمام: | edsbas.EEF8E41 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.EEF8E41 823 3 Academic Journal academicJournal 822.664306640625 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.EEF8E41&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => http://dx.doi.org/10.1111/ijd.14350# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => The role of biologics in the treatment of chronic granuloma annulare
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Chen%2C+Alessandra%22">Chen, Alessandra</searchLink><br /><searchLink fieldCode="AR" term="%22Truong%2C+Allison+K%2E%22">Truong, Allison K.</searchLink><br /><searchLink fieldCode="AR" term="%22Worswick%2C+Scott%22">Worswick, Scott</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => International Journal of Dermatology ; volume 58, issue 5, page 622-626 ; ISSN 0011-9059 1365-4632 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Wiley ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2019 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Wiley Online Library (Open Access Articles via Crossref) ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background Granuloma annulare ( GA ), a benign inflammatory skin disease, is considered a Th1‐type delayed hypersensitivity reaction. Localized GA is likely to resolve spontaneously, whereas disseminated GA ( DGA ) may persist for decades and can be resistant to treatment. Biologics including TNF ‐α inhibitors have been proposed and utilized as salvage therapy for GA and other related diseases, interstitial granulomatous dermatitis ( IGD ), and actinic granuloma ( AG ). Methods A systematic review was conducted using the combination of search terms “granuloma annulare,” “interstitial granulomatous dermatitis,” or “actinic granuloma” and either “biologics,” “etanercept,” “adalimumab,” “infliximab,” “ustekinumab,” “ixekizumab,” “secukinumab,” “guselkumab,” “golimumab,” “brodalumab,” “tildrakizumab,” or “certolizumab” from the years 1970–2017. Results Review of the literature revealed that 79.3% of the patients with GA , IGD , or AG who had been treated with demonstrated TNF ‐α inhibitor therapy a clinical response. Conclusions TNF ‐α inhibitor therapy has been used to treat chronic GA , IGD , and AG that involved extensive body surface areas. However, the literature is limited to case series lacking control groups. Randomized, controlled trials are required to establish evidence‐based treatment of GA and related cutaneous, granulomatous conditions. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1111/ijd.14350 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://dx.doi.org/10.1111/ijd.14350<br />https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijd.14350<br />https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.14350<br />https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ijd.14350 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => http://onlinelibrary.wiley.com/termsAndConditions#vor ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.EEF8E41 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1111/ijd.14350
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => The role of biologics in the treatment of chronic granuloma annulare
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Chen, Alessandra
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Truong, Allison K.
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Worswick, Scott
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2019
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => International Journal of Dermatology ; volume 58, issue 5, page 622-626 ; ISSN 0011-9059 1365-4632
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |